Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MITF | O75030 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 5/20 | 0.41 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5741754 | 0.99 | MITF (0.51) | MITFALDH1A1PTGS1PTGS2HTT | |
| SCHEMBL1594228 | 0.84 | ALDH1A1 (0.59) | MITFALDH1A1PTGS1PTGS2HTT | |
| SCHEMBL5313447 | 0.83 | MITF (0.40) | MITFALDH1A1L3MBTL1MAPTPOLB | |
| SCHEMBL1080487 | 0.81 | MITF (0.54) | MITFALDH1A1PTGS1PTGS2HTT | |
| SCHEMBL30211422 | 0.80 | MITF (0.56) | MITFALDH1A1PTGS1PTGS2HTT | |
| SCHEMBL31614495 | 0.79 | MITF (0.52) | MITFALDH1A1PTGS1PTGS2HTT | |
| SCHEMBL2028204 | 0.78 | CYP1A2 (0.44) | ALDH1A1MAPTPOLBKMT2AGAA | |
| SCHEMBL3287960 | 0.78 | ALDH1A1 (0.41) | MITFALDH1A1L3MBTL1LMNAKMT2A | |
| SCHEMBL1594872 | 0.78 | MITF (0.51) | MITFALDH1A1PTGS1PTGS2HTT | |
| SCHEMBL31614485 | 0.78 | MITF (0.48) | MITFALDH1A1PTGS1PTGS2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116120238-B | Preparation method of imidazole derivative | 山东梅奥华卫科技有限公司 | 2023-09-22 | — | — | CN | claimed |
| CN-116120238-A | Preparation method of imidazole derivative | 山东梅奥华卫科技有限公司 | 2023-05-16 | — | — | CN | claimed |
| US-20250368628-A1 | METHODS AND COMPOUNDS FOR MODULATING INHERITED GENETIC DISEASES | DESIGN THERAPEUTICS INC (US) | 2025-12-04 | — | — | US | disclosed |
| US-20250295632-A1 | COMPOUNDS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA | Design Therapeutics, Inc. | 2025-09-25 | — | — | US | disclosed |
| EP-4539839-A1 | METHODS AND COMPOUNDS FOR MODULATING INHERITED GENETIC DISEASES | Design Therapeutics, Inc. (US) | 2025-04-23 | — | — | EP | disclosed |
| EP-4539842-A1 | METHODS AND COMPOUNDS FOR MODULATING INHERITED GENETIC DISEASES | Design Therapeutics, Inc. (US) | 2025-04-23 | — | — | EP | disclosed |
| WO-2025076181-A1 | METHODS AND COMPOUNDS FOR MODULATING HUNTINGTON'S DISEASE | Design Therapeutics, Inc. (US) | 2025-04-10 | — | — | WO | disclosed |
| US-20250109132-A1 | COMPOUNDS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA | DESIGN THERAPEUTICS INC (US) | 2025-04-03 | — | — | US | disclosed |
| CN-119677513-A | Methods and compounds for modulating genetic disease | 设计治疗公司 | 2025-03-21 | — | — | CN | disclosed |
| EP-4522168-A1 | COMPOUNDS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA | Design Therapeutics, Inc. (US) | 2025-03-19 | — | — | EP | disclosed |
| EP-4460302-A2 | COMPOUNDS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA | Design Therapeutics, Inc. (US) | 2024-11-13 | — | — | EP | disclosed |
| WO-2001088160-A2 | VECTORS FOR DNA DELIVERY | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI, S.P.A. (IT) | 2001-11-22 | — | — | WO | disclosed |
| US-6303312-B1 | MODIFYING CELL PHENOTYPE; MEDICAL RESEARCH AND THERAPY | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2001-10-16 | — | — | US | disclosed |
| US-6143901-A | FORMINGA SPECIFIC COMPLEX BETWEEN A TARGET SEQUENCE OF DOUBLE STRANDED DNA AND AN OLIGOMER OR POLYMER OF N-METHYLPYRROLE CARBOXAMIDE AND N-METHYLIMIDAZOLE CARBOXAMID WHEREIN N-HETEROCYLCES ARE CONNCETED WITH AN AMINO ACID LINKING GROUP | GENESOFT, INC. (US) | 2000-11-07 | — | — | US | disclosed |
| US-6090947-A | Method for the synthesis of pyrrole and imidazole carboxamides on a solid support | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2000-07-18 | — | — | US | disclosed |
| EP-0991417-A1 | COMPLEX FORMATION BETWEEN DSDNA AND OLIGOMER OF HETEROCYCLES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2000-04-12 | — | — | EP | disclosed |
| EP-0986539-A1 | DNA-BINDING PYRROLE AND IMIDAZOLE POLYAMIDE DERIVATIVES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2000-03-22 | — | — | EP | disclosed |
| US-5998140-A | COMPLEXES OF CELL WITH OLIGOMER | THE SCRIPPS RESEARCH INSTITUTE (US) | 1999-12-07 | — | — | US | disclosed |
| WO-1998050058-A1 | COMPLEX FORMATION BETWEEN DSDNA AND OLIGOMER OF HETEROCYCLES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1998-11-12 | — | — | WO | disclosed |
| WO-1998049142-A1 | DNA-BINDING PYRROLE AND IMIDAZOLE POLYAMIDE DERIVATIVES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1998-11-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250368628-A1 | METHODS AND COMPOUNDS FOR MODULATING INHERITED GENETIC DISEASES | CLN6, GATAD2B, MITF | MITF 3/4885ALDH1A1 4027/4885PTGS1 3394/4885 |
| US-20250295632-A1 | COMPOUNDS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA | ATXN2, CLN6, ATXN2L | MITF 753/4885ALDH1A1 3096/4885PTGS1 3037/4885 |
| US-20250109132-A1 | COMPOUNDS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA | ATXN2, ATXN2L, ATXN10 | MITF 183/4885ALDH1A1 4371/4885PTGS1 3864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.